精华制药(002349) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was CNY 416,357,917.91, representing a 1.87% increase compared to CNY 408,730,383.60 in the same period last year[5] - Net profit attributable to shareholders increased by 31.14% to CNY 87,671,328.30 from CNY 66,855,252.60 year-on-year[5] - The net profit after deducting non-recurring gains and losses rose by 37.56% to CNY 85,573,376.48 compared to CNY 62,208,068.96 in the previous year[5] - The company's basic and diluted earnings per share increased by 31.18% to CNY 0.1077 from CNY 0.0821 in the same quarter last year[5] - Net profit for Q1 2023 was CNY 99,041,270.14, compared to CNY 74,853,545.20 in the same period last year, indicating an increase of approximately 32.16%[19] - The net profit attributable to the parent company for Q1 2023 was ¥87,671,328.30, an increase of 31.1% compared to ¥66,855,252.60 in Q1 2022[20] - The total comprehensive income for the parent company was ¥87,671,328.30, up from ¥66,855,252.60, reflecting a growth of 31.1% year-over-year[20] - Basic and diluted earnings per share for Q1 2023 were both ¥0.1077, compared to ¥0.0821 in the same period last year, representing a 31.1% increase[20] Assets and Liabilities - Total assets at the end of Q1 2023 were CNY 3,091,955,034.11, a 1.65% increase from CNY 3,041,677,568.76 at the end of the previous year[5] - Total assets amounted to CNY 3,091,955,034.11, up from CNY 3,041,677,568.76, indicating a growth of about 1.65%[17] - Total liabilities decreased to CNY 367,934,315.21 from CNY 417,934,051.11, a reduction of approximately 11.97%[17] Cash Flow - The company's cash flow from operating activities turned negative at CNY -5,318,150.98, a decline of 110.85% compared to CNY 49,036,733.84 in the same period last year[5] - Cash inflow from operating activities totaled ¥335,773,634.65, down from ¥397,627,479.43 in Q1 2022, indicating a decrease of 15.6%[23] - The net cash flow from operating activities was negative at -¥5,318,150.98, compared to a positive ¥49,036,733.84 in the previous year[23] - Cash inflow from investment activities was ¥52,212,131.92, a decrease of 60.5% from ¥132,045,365.89 in Q1 2022[23] - The net cash flow from investment activities was -¥5,548,102.56, compared to -¥35,780,083.95 in the same period last year, showing an improvement[23] - The net cash flow from financing activities was -¥233,372.22, compared to -¥63,737,246.56 in Q1 2022, indicating a significant reduction in cash outflow[23] - The total cash and cash equivalents decreased by ¥12,937,676.99 during the quarter, compared to a decrease of ¥50,824,863.51 in the previous year[23] Receivables and Payables - The company reported a significant increase in accounts receivable by 72.08%, reaching CNY 39,301,314.34 due to an increase in bank notes received[9] - Other receivables rose by 54.58% to CNY 4,178,705.94, attributed to increased receivables from a subsidiary[9] - Accounts receivable increased to CNY 260,391,030.56 from CNY 219,069,324.58, marking an increase of about 18.87%[16] - The company experienced a 45.86% decrease in contract liabilities, down to CNY 24,416,332.85, due to reduced pre-sales[9] Expenses - Total operating costs decreased to CNY 298,578,026.85 from CNY 317,954,488.35, reflecting a reduction of about 6.06%[19] - The company reported a decrease in selling expenses to CNY 47,267,598.34 from CNY 58,811,849.14, a decline of about 19.66%[19] - Research and development expenses were CNY 13,215,026.76, down from CNY 14,784,119.29, representing a decrease of approximately 10.59%[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 148,231, with no preferred shareholders[12] - The largest shareholder, Nantong Industrial Holdings Group Co., Ltd., holds 34.39% of the shares, totaling 279,994,660 shares[12] Other Financial Metrics - The company recorded a 54461.01% increase in non-operating income, amounting to CNY 422,029.41, due to higher income unrelated to daily operations[9] - The company reported a 71.93% increase in tax payments, totaling CNY 53,233,443.50, due to reduced tax deferral benefits from the previous year[10] - Cash received from investment decreased by 60.41% to CNY 51,900,000.00, attributed to fewer maturing financial products compared to the same period last year[10] - The company reported a 71.98% decrease in cash received from investment income, totaling CNY 259,331.92, due to fewer maturing financial products[10] - Cash flow from the disposal of fixed assets increased by 230.00% to CNY 52,800.00, driven by more asset disposals by a subsidiary[10] - The company did not receive any cash from borrowings during the reporting period, marking a 100% decrease compared to the previous year[10] - The impact of exchange rate fluctuations on cash and cash equivalents was a negative CNY 1,838,051.23, reflecting significant currency volatility[10] Audit Information - The company did not conduct an audit for the Q1 2023 report[25]